Medicare Enrolled

Dr. Edward Fox, M.D. PH.D.

Neurology · Round Rock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
16040 PARK VALLEY DR, Round Rock, TX 78681
5122181222
In practice since 2006 (19 years)
NPI: 1871528042 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fox from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fox? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fox

Dr. Edward Fox is a neurology in Round Rock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Fox performed 9,222 Medicare services across 185 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fox received a total of $702,505 from 64 pharmaceutical and/or device companies across 1179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fox is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $702,505 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,222
Medicare services
Top 9% in TX for neurology
185
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~485 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Ocrelizumab infusion (Ocrevus) for MS9,000$44$165
Office visit, established patient (30-39 min)93$64$203
Injection, methylprednisolone sodium succinate, up to 125 mg55$4$27
Injection of additional new drug or substance into vein27$6$50
Administration of chemotherapy into vein, 1 hour or less16$65$320
Administration of chemotherapy into vein, each additional hour16$15$125
Injection, diphenhydramine hcl, up to 50 mg15$1$10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
97.6% high complexity
1.4% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$702,505
Total received (2018-2024)
Avg $100,358/year across 7 years
Top 1% in TX for neurology
64
Companies
1,179
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$545,865 (77.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$129,070 (18.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,569 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168
2023
$16,008
2022
$150,516
2021
$95,134
2020
$127,210
2019
$125,187
2018
$188,282

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$221,317
Genentech USA, Inc.
$86,198
Celgene Corporation
$63,090
E.R. Squibb & Sons, L.L.C.
$60,492
EMD Serono, Inc.
$57,597
Novartis Pharmaceuticals Corporation
$44,800
Alexion Pharmaceuticals, Inc.
$36,896
Horizon Therapeutics plc
$29,081
TG Therapeutics, Inc.
$17,724
Novartis Pharma AG
$12,086
Genentech, Inc.
$11,996
TG THERAPEUTICS, INC.
$9,346
F. Hoffmann-La Roche AG
$9,051
Bayer HealthCare Pharmaceuticals Inc.
$8,287
Teva Pharmaceuticals USA, Inc.
$6,875
Greenwich Biosciences, Inc.
$6,425
GENZYME CORPORATION
$5,508
Acorda Therapeutics, Inc
$3,663
Janssen Pharmaceuticals, Inc
$2,913
NOVARTIS PHARMACEUTICALS CORPORATION
$2,899
UCB, Inc.
$891
Chugai Pharmaceutical Co., Ltd.
$750
Amgen Inc.
$559
Daiichi Sankyo Inc.
$348
PFIZER INC.
$309
ACADIA Pharmaceuticals Inc
$276
Neurocrine Biosciences, Inc.
$265
Lundbeck LLC
$242
Mitsubishi Tanabe Pharma America, Inc.
$239
Sunovion Pharmaceuticals Inc.
$212
Lilly USA, LLC
$170
Avanir Pharmaceuticals, Inc.
$134
Merz North America, Inc.
$121
Biohaven Pharmaceuticals, Inc.
$118
AbbVie Inc.
$105
Jazz Pharmaceuticals Inc.
$101
Currax Pharmaceuticals LLC
$97
SK Life Science, Inc.
$97
JAZZ PHARMACEUTICALS INC.
$85
Medtronic, Inc.
$84
Upsher-Smith Laboratories LLC
$79
SANOFI-AVENTIS U.S. LLC
$72
ABBVIE INC.
$70
UPSHER-SMITH LABORATORIES LLC
$69
Kyowa Kirin, Inc.
$66
ARGENX US, INC.
$65
Biohaven Pharmaceutical Holding Company Ltd.
$62
MITSUBISHI TANABE PHARMA AMERICA, INC.
$62
Bausch Health US, LLC
$61
Mallinckrodt LLC
$46
US WorldMeds, LLC
$45
Mallinckrodt Enterprises LLC
$42
Grifols USA, LLC
$41
Abbott Laboratories
$37
Allergan, Inc.
$36
Octapharma USA, Inc.
$33
Pernix Therapeutics Holdings, Inc.
$27
Amylyx Pharmaceuticals, Inc.
$25
Assertio Therapeutics, Inc.
$24
Sumitomo Pharma America, Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$22
Alkermes, Inc.
$21
Shire North American Group Inc
$15
MDD US Operations, LLC
$15
Top 3 companies account for 52.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · APTIOM · ARISTADA · AUBAGIO · AUSTEDO · Aimovig · BRIUMVI · Betaseron · Briviact · CAMBIA · CHANTIX · COMIRNATY · CONTRAVE · COPAXONE · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FTY720D · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Non-Covered Product · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OMB157B · Ocrevus · Ozanimod · PANZYGA · Ponvory · QULIPTA · RADICAVA · RELYVRIO · RYLAZE · Radicava · Rebif · SOLIRIS · SPINRAZA · SUNOSI · SYNCHROMEDII · Soliris · Strensiq · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · Turalio · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · Vimpat · XEOMIN · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in TX.

Equivalent to $7,618 per 100 Medicare services performed
Looking for a neurology in Round Rock?
Compare neurologys in the Round Rock area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
121
Per 100K population
18.8
County median income
$108,309
Nearest hospital
ROUND ROCK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fox is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fox experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Fox performed 9,000 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fox receive payments from pharmaceutical companies?
Yes. Dr. Fox received a total of $702,505 from 64 companies across 1,179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fox's costs compare to other neurologys in Round Rock?
Dr. Fox's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fox) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →